Six IPOs Raising More than a Half-Billion This Week

Six biopharmas are raising more than a half-billion dollars gross this week through initial public offerings, five of which are planned for today—a sign that the IPO market remains robust, at least for now.The six are among 28 U.S. biopharmas that have launched IPOs this year, according to Brad Loncar, CEO of Loncar Investments, who tracks developments in cancer immunotherapy and the broader biopharma industry.Thirteen of those 28 IPO companies have seen their stock prices rise above their